A DAILY pill for the most common form of bladder cancer has been given the green light for NHS use. Erdafitinib, which blocks ...

Once-a-day tablet for bladder cancer to be rolled out on NHS - Hundreds of patients are expected to benefit from the ...

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...

The first targeted treatment for the most common form of bladder cancer has been given the green light for NHS ... The drug, also known as Balversa and made by Johnson & Johnson, is taken as a ...

The first targeted treatment for the most common form of bladder cancer has been given the green ... is taken as a once-a-day tablet and works by blocking certain proteins to slow down or stop ...